Evidence map›Paper›PMID 11939905›Full record

ArticleThe Biochemical journal2002

Mechanism of negative regulation of rat glutathione S-transferase A2 by the cytokine interleukin 6.

Susan H Voss, Richard Whalen, Thomas D Boyer

Open access · bronzeAbstract read
In one paragraph

Article in The Biochemical journal, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Hepatocyte nuclear factor 1 and hypertensive nephropathy.Hypertension (Dallas, Tex. : 1979) · 2008
    Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Susan H VossDepartment of Pathology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Richard Whalen
Thomas D Boyer
University of Arizona · USEmory University · US

Funding

FACTORS IN THE PREVENTION OF TOXIC LIVER INJURYR01GM031555 · NIGMS · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI BOYER, THOMAS D. · 1985 to 2008
$2.7M
NIGMS NIH HHS GM 31555
6 · The paper itself

Abstract

A decrease in concentration of some liver proteins, including the detoxification enzyme glutathione S-transferase A2 (rGSTA2), occurs during the acute-phase response. Interleukin 6 (IL-6) with dexamethasone (DEX) decreases transcription of rGSTA2 in rat hepatocytes. The promoter region that mediates suppression of rGSTA2 was localized to 150 bp. These 150 bp were divided and used for electrophoretic mobility-shift assays. Induction of a protein that specifically bound to an oligonucleotide from this region required new protein synthesis and IL-6 with DEX in the culture media. The protein bound to part of the hepatocyte nuclear factor 1 (HNF1) site but was different from and did not displace HNF1. A core sequence, TGATT, was required for binding. The protein also bound to an HNF1 site in the albumin promoter. We hypothesize that IL-6 along with DEX induced a novel protein that decreased transcription of rGSTA2 and possibly albumin by interfering with the transactivating function of HNF1. The protein may be an important negative regulator of transcription during the acute-phase response.

Indexed as

Acute-Phase ReactionAlbuminsAnimalsBase SequenceBinding SitesCells, CulturedChloramphenicol O-AcetyltransferaseDexamethasoneDNAGenes, ReporterGlutathione TransferaseHepatocytesInterleukin-6Promoter Regions, GeneticRatsTranscription, GeneticAlbuminsChloramphenicol O-AcetyltransferaseDexamethasoneDNAGlutathione TransferaseInterleukin-6

Identifiers

PMID11939905
PMCPMC1222648
OpenAlexW2032735971

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.